Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks fall as US inflation tops expectations

Tue, 13th Feb 2024 16:21

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

The FTSE 100 closed down 0.81% at 7,512.28 points, while the FTSE 250 fell 1.46% to settle at 18,923.83 points.

In currency markets, sterling was last down 0.21% on the dollar to trade at $1.2602, while it managed a modest uptick against the euro, gaining 0.33% to change hands at €1.1762.

"January consumer price inflation falling less than expected was enough of a catalyst to cut the equity rally short, push yields and the US dollar to two-month highs," said IG senior market analyst Axel Rudolph.

"Hopes for a Fed March rate cut have all but disappeared with the market now pricing in a 53% probability of a first cut being seen in June."

Rudolph said the Brent crude oil price was on track for its seventh straight day of gains, albeit at a slower pace, as investors mulled over the situation in the Middle East and supply concerns.

"US natural gas prices continue to slide, though, and hit their lowest level since July 2020 amid ample production levels and subdued demand due to more clement weather.

"The higher-than-expected US CPI reading provoked a sharp decline in the gold price with it now trading in two-month lows below the psychological $2,000 per troy ounce mark."

Unemployment rate decreases in UK, US inflation remains hot

In economic news, the Office for National Statistics reported that the unemployment rate for individuals aged 16 and over decreased to 3.8% in the three months to December, down from November's 4.2% and surpassing expectations for 4.0%.

However, the economic inactivity rate rose to 21.9%, primarily driven by the number of long-term sick individuals, which remained notably high.

Claimant counts for January increased by 14,100 on a monthly basis and 61,200 on a yearly basis, totalling 1.579 million.

Despite that, the employment rate stood at 75.0%.

Vacancies fell by 26,000 in the quarter, marking the 19th consecutive month of decline, although they still surpassed pre-pandemic levels.

Notably, wage growth exceeded forecasts, with average regular earnings for employees, excluding bonuses, rising by 6.2% annually, contrasting with predictions of 6.0%.

Including bonuses, wages grew by 5.8%.

Real-term annual growth for total pay was 1.4%, and 1.8% for regular pay.

However, the ONS expressed caution regarding labour force survey (LFS) estimates due to smaller sample sizes resulting from changes in methodology.

"Official data continue to suggest that the labour market remains tight, though their veracity remains questionable," said Samuel Tombs, chief UK economist at Pantheon Macroeconomics.

"The latest LFS estimates are based on the ONS' new population projections, but work to boost the response rate remains incomplete.

"Accordingly, the ONS says that the data should be treated with additional caution."

Tombs said the recent dip in the unemployment rate from its post-Covid peak of 4.3% in July looked "particularly suspect".

"Many surveys indicate that staff availability for vacancies has improved."

Meanwhile, inflation in the US surged beyond expectations in January, driven largely by increases in shelter prices.

According to the Bureau of Labor Statistics, the consumer price index rose by 3.1% year-on-year, exceeding the anticipated 2.9% increase and marking a continuation from December's 3.4% rise.

Core CPI, excluding food and energy prices, increased by 0.4% last month and stood at 3.9% higher annually, outpacing forecasts.

Notably, shelter prices, comprising a significant portion of the CPI, rose by 0.6% monthly, contributing substantially to the overall increase, while food prices also saw a 0.4% uptick.

However, energy prices declined by 0.9%, largely due to a 3.3% drop in gas prices.

Finally on data, there was a notable improvement in economic sentiment in Germany according to a closely-monitored survey.

The latest ZEW indicator of economic sentiment rose by 4.7 points in February, reaching 19.9, marking the seventh consecutive month of increase.

However, the indicator reflecting the current economic situation dropped by 4.4 points to -81.7, the lowest since June 2020, at the onset of the pandemic.

Housebuilders fall on jobs data, Aston Martin in the green

On London's equity markets, housebuilders and property-related firms were in focus, with Persimmon, Barratt Developments, Taylor Wimpey, and Rightmove all suffering losses of between 3.04% and 4.59%.

The downturn followed the release of the UK jobs data, which hinted at the potential for prolonged higher interest rates, thereby impacting sentiment in the property market.

Crest Nicholson, Redrow, Shaftesbury Capital, UK Commercial Property REIT, and Tritax EuroBox also registered declines in response to the aforementioned news, with Crest Nicholson tumbling 6.37%.

Travel firm TUI closed marginally lower despite reporting a positive quarterly underlying profit and affirming its full-year guidance.

The company's underlying earnings before interest and tax for the last quarter were €6 million, marking a significant milestone since the merger of TUI AG and TUI Travel plc in 2014.

Group revenues also saw a notable increase of 15% year-on-year, driven by improved demand and pricing.

On the upside, luxury car maker Aston Martin Lagonda increased 1.13%, attributed to statements from executive chairman Lawrence Stroll regarding efforts to address the company's significant debt.

Stroll confirmed ongoing discussions with bankers to tackle a looming debt pile, which currently stood at $1.4bn.

Pharmaceutical giant GSK managed gains of 0.95% rise following a broker upgrade from Citi, which shifted its rating from 'neutral' to 'buy'.

Citi cited promising data related to GSK's novel treatment for multiple myeloma, Blenrep, as well as other positive indicators.

The bank's upgraded earnings per share forecasts, reflecting peak Blenrep revenues of about £2.5bn, underscored the newfound confidence in GSK's prospects.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,512.28 -0.81%

FTSE 250 (MCX) 18,923.83 -1.46%

techMARK (TASX) 4,340.39 -1.09%

FTSE 100 - Risers

AstraZeneca (AZN) 9,600.00p 1.04%

GSK (GSK) 1,641.80p 0.95%

Centrica (CNA) 135.55p 0.82%

HSBC Holdings (HSBA) 610.50p 0.35%

Anglo American (AAL) 1,756.00p 0.25%

BP (BP.) 479.75p 0.06%

Hikma Pharmaceuticals (HIK) 1,960.00p 0.03%

Severn Trent (SVT) 2,495.00p 0.00%

Unilever (ULVR) 3,992.50p -0.01%

Smith & Nephew (SN.) 1,096.50p -0.14%

FTSE 100 - Fallers

Barratt Developments (BDEV) 466.10p -4.59%

Taylor Wimpey (TW.) 141.15p -4.39%

Fresnillo (FRES) 471.80p -4.38%

Entain (ENT) 973.80p -4.25%

Persimmon (PSN) 1,361.50p -4.05%

Airtel Africa (AAF) 98.70p -3.89%

Scottish Mortgage Inv Trust (SMT) 779.60p -3.45%

Berkeley Group Holdings (The) (BKG) 4,577.00p -3.44%

RS Group (RS1) 765.00p -3.21%

Ocado Group (OCDO) 519.60p -3.20%

FTSE 250 - Risers

Plus500 Ltd (DI) (PLUS) 1,822.00p 1.62%

Auction Technology Group (ATG) 564.00p 1.44%

SDCL Energy Efficiency Income Trust (SEIT) 57.00p 1.24%

PPHE Hotel Group Ltd (PPH) 1,230.00p 1.23%

easyJet (EZJ) 553.40p 1.21%

JPMorgan Japanese Inv Trust (JFJ) 511.00p 0.99%

Diversified Energy Company (DEC) 915.50p 0.88%

Trustpilot Group (TRST) 185.70p 0.70%

Baltic Classifieds Group (BCG) 229.50p 0.66%

Balanced Commercial Property Trust Limited (BCPT) 78.50p 0.64%

FTSE 250 - Fallers

Crest Nicholson Holdings (CRST) 211.60p -6.37%

UK Commercial Property Reit Limited (UKCM) 63.60p -5.50%

Close Brothers Group (CBG) 402.20p -5.45%

Tritax Eurobox (GBP) (EBOX) 47.60p -4.80%

Great Portland Estates (GPE) 366.60p -4.68%

Mobico Group (MCG) 79.25p -4.58%

Redrow (RDW) 654.00p -4.55%

Bridgepoint Group (Reg S) (BPT) 264.60p -4.20%

IWG (IWG) 190.60p -4.12%

Abrdn (ABDN) 158.90p -3.90%

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.